RxDoctor Payments Data

John Uhl, MD

Emergency Medicine · New Orleans, LANPI 1891987160

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,946 of the $9,992 with a category attached, or 69.5%. 19 manufacturers reported payments, led by Abbott at 32.9% of the total. Reporting peaked in 2022 at $3,477 and has fallen 71.0% since, to $1,008 in 2025. Among emergency medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,992in general payments, 2019–2025

Across 209 payments — averaging $47.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Boston Scientific$3K
  • Relievant Medsystems, Inc.$2K
  • Medtronic$2K
  • Nevro Corp.$279
  • Collegium Pharmaceutical, Inc.$182
  • plus $667 from 13 others

What the payments were for

  • Travel & lodging$3,04630%
  • Food & beverage$6,94670%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,992 in reported general payments places this provider in the 95th percentile of 881 emergency medicine providers in Louisiana.

See all emergency medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$136,541
Medicare patients
375
Services billed
1,432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen3,588$78,026
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,132$63,810
BelbucaBuprenorphine Hcl76$63,137
MovantikNaloxegol Oxalate63$25,345
Xtampza ErOxycodone Myristate30$19,252
Gabapentin1,112$13,492
Buprenorphine26$7,805
Pregabalin716$7,252
OxycontinOxycodone Hcl15$7,199
Oxycodone Hcl320$7,062
Nabumetone692$7,038
Lidocaine39$6,710
Tramadol Hcl789$5,999
Tizanidine Hcl584$4,990
Baclofen470$4,658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$182$82,390106 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 881 emergency medicine providers in Louisiana.

Other emergency medicine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →